Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family
- PMID: 31923348
- PMCID: PMC7005610
- DOI: 10.1002/mgg3.1060
Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family
Abstract
Background: Xeroderma pigmentosum (XP) is a rare genetic disorder, which is characterized by hyper-sensitivity to solar ultraviolet (UV) radiation. Clinical consequences of sun exposure are skin lesions and an increased risk of developing skin cancer. Genetic studies have identified eight genes associated with xeroderma pigmentosum. The proteins encoded by these genes are mainly involved in DNA repair mechanisms.
Methods: Molecular genetic characterization of patients with xeroderma pigmentosum involved positional cloning methods such as homozygosity mapping and subsequent candidate gene analysis. Mutation screening was performed through Sanger DNA sequencing.
Results and discussion: In this case study, we report a novel protein truncating mutation in XPC associated with autosomal recessive xeroderma pigmentosum in a consanguineous Pakistani family. Genetic mapping revealed a novel single base insertion of a thymine nucleotide NM_004628.4: c.291dupT (c.291_292insT) in the second exon of XPC. The identified mutation leads to a premature stop codon (TGA) at amino acid position 98 (p.Asp98*) and thus presumably results in a truncated protein. The Xeroderma pigmentosum, complementation group C (XPC) is located on 3p25.1 and encodes a protein involved in nucleotide excision repair. The identified mutation presumably truncates all functional domains of the XPC protein, which likely results in the loss of protein function.
Conclusion: The study expands the knowledge of the mutational spectrum of XPC and is valuable for genetic counseling of affected individuals and their families.
Keywords: XPC; Pakistani family; frameshift mutation; homozygosity mapping; xeroderma pigmentosum.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare that they have no financial as well as competing interest.
Figures

References
-
- Bradford, P. T. , Goldstein, A. M. , Tamura, D. , Khan, S. G. , Ueda, T. , Boyle, J. , … Kraemer, K. H. (2011). Cancer and neurologic degeneration in xeroderma pigmentosum: Long term follow‐up characterises the role of DNA repair. Journal of Medical Genetics, 48(3), 168–176. 10.1136/jmg.2010.083022 - DOI - PMC - PubMed
-
- Chavanne, F. , Broughton, B. C. , Pietra, D. , Nardo, T. , Browitt, A. , Lehmann, A. R. , & Stefanini, M. (2000). Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Research, 60(7), 1974–1982. - PubMed
-
- Fassihi, H. , Sethi, M. , Fawcett, H. , Wing, J. , Chandler, N. , Mohammed, S. , … Lehmann, A. R. (2016). Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect. Proceedings of the National Academy of Sciences, 113(9), E1236–E1245. 10.1073/pnas.1519444113 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources